Skip to main content

What the FDA labels say about taking them together

Ciprofloxacin and methotrexate

Ciprofloxacin's FDA label of March 2, 2026 names methotrexate in its drug interactions section; the methotrexate labels PlainMeds reads (4) do not name ciprofloxacin. The ciprofloxacin label: “Methotrexate; Use with caution Inhibition of methotrexate renal tubular transport potentially leading to increased methotrexate plasma levels; Potential increase in the risk of methotrexate associated toxic reactions. …”

Check it at the source: the ciprofloxacin FDA label on DailyMed (effective March 2, 2026, Bayer HealthCare Pharmaceuticals Inc.); the methotrexate FDA label on DailyMed (effective May 27, 2026, Accord Healthcare Inc.).

What does the ciprofloxacin label say about methotrexate?

Ciprofloxacin label, drug interactions

Methotrexate; Use with caution Inhibition of methotrexate renal tubular transport potentially leading to increased methotrexate plasma levels; Potential increase in the risk of methotrexate associated toxic reactions. Therefore, carefully monitor patients under methotrexate therapy when concomitant CIPRO therapy is indicated.

Source: FDA drug label (Cipro), Bayer HealthCare Pharmaceuticals Inc., effective March 2, 2026 (SPL set 888dc7f9-ad9c-4c00-8d50-8ddfd9bd27c0), via openFDA; the full label on DailyMed

What does the methotrexate label say about ciprofloxacin?

Methotrexate's label (effective May 27, 2026) and its 3 other brand-application labels do not name ciprofloxacin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Methotrexate), Accord Healthcare Inc., effective May 27, 2026 (SPL set 874c7f43-a3be-4236-89cc-24c44e3c5813), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

54Ciprofloxacin generic labelers
29Methotrexate generic labelers
CiprofloxacinMethotrexate
Labeled forDiarrhea, Urinary tract infections, Bacterial infectionsRheumatoid arthritis, Psoriasis, Leukemia, lymphoma and myeloma, Breast cancer
Boxed warningYesYes
Pharmacy cost (NADAC)$0.123 per tablet 500 mg tablet$0.158 per tablet 2.5 mg tablet
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?